Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism

Eur J Contracept Reprod Health Care. 2022 Apr;27(2):83-84. doi: 10.1080/13625187.2022.2029397. Epub 2022 Feb 8.

Authors

Giovanni Grandi¹, Fabio Facchinetti¹, Johannes Bitzer²

Affiliations

¹ Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, University Hospital Polyclinic, Modena, Italy.
² Department of Obstetrics and Gynaecology, University Hospital, University of Basel, Basel, Switzerland.

PMID: 35133236
DOI: 10.1080/13625187.2022.2029397

No abstract available

Publication types

Editorial
Comment

MeSH terms

Contraceptives, Oral, Combined* / adverse effects
Desogestrel
Estradiol / adverse effects
Female
Humans
Risk Factors
Venous Thromboembolism* / chemically induced

Substances

Contraceptives, Oral, Combined
Estradiol
Desogestrel